Sinopharm
1099.HK
#2290
Rank
ยฃ5.17 B
Marketcap
ยฃ1.67
Share price
0.94%
Change (1 day)
-25.70%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : ยฃ7.95 B

According to Sinopharm's latest financial reports the company's total debt is ยฃ7.95 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31ยฃ11.32 B42.87%
2021-12-31ยฃ7.92 B3.01%
2020-12-31ยฃ7.69 B29.4%
2019-12-31ยฃ5.94 B-5.28%
2018-12-31ยฃ6.27 B48.25%
2017-12-31ยฃ4.23 B8.34%
2016-12-31ยฃ3.90 B29.78%
2015-12-31ยฃ3.01 B-1.42%
2014-12-31ยฃ3.05 B21.48%
2013-12-31ยฃ2.51 B57.14%
2012-12-31ยฃ1.60 B12.92%
2011-12-31ยฃ1.41 B319.86%
2010-12-31ยฃ0.33 B115.4%
2009-12-31ยฃ0.15 B-5.76%
2008-12-31ยฃ0.16 B4.45%
2007-12-31ยฃ0.15 B29.37%
2006-12-31ยฃ0.12 B